Pharma Clinical Trial Services: World Market 2013-2023

  • January 2013
  • -
  • Visiongain
  • -
  • 189 pages

Report Details

Discover new trends, opportunities and prospects for contract clinical trials

What's the outlook for clinical research providers? Visiongain's updated report gives you forecasted revenues to 2023. It explains trends, opportunities and commercial prospects.

Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in clinical trial outsourcing, helping your research and analyses.

Forecasts and other analyses to help you stay ahead in knowledge

In our work you find revenue forecasting to 2023, historical data, growth rates and market shares. Also, you see qualitative analysis (SWOT and STEP), business news, outlooks and developmental trends (R&D). You receive 74 tables, 61 charts and two survey interviews.

There's rising demand for that pharma research. The outsourced clinical trials market will increase its revenues from 2013 to 2023, achieving strong growth. Clinical research organisations (CROs) and their clients will benefit.

The following sections show what you find in our new report.

Discover prospects for the world market and submarkets

Along with revenue prediction for the overall world market, you see forecasts to 2023 for eight submarkets:
• Early phase clinical trial services
• Late phase services.

We also show forecasts for contract services by therapeutic area:
• Cancers
• Central nervous system (CNS) diseases
• Cardiovascular diseases
• Infections
• Metabolic disorders
• Other therapy areas (grouped prediction).

You gain advantages by understanding trends, opportunities and challenges. Our investigation shows what will stimulate and restrain business for CROs.

Our work also breaks the main world forecast into geographical markets.

What prospects for leading regions and countries?

Developments worldwide will influence the market from 2013, especially improving clinical research in developing countries. There exist many opportunities for pharmaceutical companies and contract research providers. See outlooks for clinical testing.

You get individual forecasts to 2023 for 12 national markets and two regional groups, finding overall revenues:
• US
• Japan
• Western Europe
• Central and Eastern Europe (CEE)
• Germany, France, UK, Italy and Spain (EU5)
• Brazil, Russia, India and China (BRIC nations) and South Korea.

Discover progress and outlooks. You assess the industry's future - hear about developments and find their significance. Our work explains, exploring many issues.

What affects clinical trial services from 2013?

Our report discusses issues and events affecting that industry and market from 2013:
• Future of outsourced phase I, II and III trials and post-marketing studies
• Demand from pharmaceutical and biopharma companies
• Regulatory policy
• Challenges in developed and developing countries
• Adaptive trial designs and focus on late-stage R&D pipeline candidates
• Patient recruitment and retention.

Also, we discuss these aspects of the field:
• Social media as tools for engaging patients
• Technological progress for more-efficient trials
• Sharing of risk between the pharma industry and CROs
• CRO consolidation, specialisation and globalisation
• Studies on orphan diseases
• Biomarkers in drug development.

See what the future holds. You investigate technological, economic and political matters, finding emphasis on companies, competition and business outlooks.

Leading companies and 2015 market value

We predict that the overall world market for clinical trial services will reach $30.6bn in 2015, and expand further to 2023. That outsourcing segment holds great potential for investment, development and revenue growth from 2013. You

Table Of Contents

Table of Contents

1. Executive Summary
1.1 Pharma Clinical Trial Services: World Market Review
1.2 Report Contents
1.3 Research and Analysis Methods

2. An Introduction to Clinical Trial Outsourcing
2.1 A Brief History of Clinical Trials
2.2 Clinical Trial Design and Execution
2.2.1 Phases of Clinical Trials
2.2.1.1 Phase I Trials: First-in-Human Studies
2.2.1.2 Phase II Trials: Proof-of-Concept
2.2.1.3 Phase III Trials: Preparing for Approval Applications
2.2.1.4 Post-Marketing Studies
2.2.2 Key Elements of Clinical Trials
2.2.3 Common Trial Designs
2.2.3.1 Improving Clinical Trial Models Through Adaptive Trial Designs
2.3 Clinical Trial Outsourcing
2.3.1 Challenges Exist in Conducting Clinical Trials
2.3.2 Benefits of Outsourcing

3. The World Pharma Clinical Trial Services Market 2013-2023
3.1 The Pharma Clinical Trial Services Market 2011-2012
3.1.1 Rapid Growth in the Clinical Trial Outsourcing Market 2008-2011
3.1.2 CRO Revenue by Trial Phase 2011
3.1.3 Big Pharma Companies Are the Leading Clients for CROs
3.2 The Pharma Clinical Trial Services Market 2013-2023
3.2.1 What Will Drive Growth in Clinical Trial Outsourcing 2013-2023?
3.2.2 The Pharma Clinical Trial Services Market: Overall Revenue Forecast 2013-2023
3.2.3 Which Market Sector Will Account for Most Revenue 2013-2023?
3.3 Early Phase Clinical Trial Services 2013-2023
3.3.1 Rising Demand for Early Phase Services Throughout the Decade
3.3.2 Biotech Outsourcing to Drive Early Phase Growth
3.4 Late Phase Clinical Trial Services 2013-2023
3.4.1 Late Phase Clinical Trial Services: The Largest Market Sector 2013-2023
3.4.2 Focus on Last-Stage Pipeline Candidates Early in the Decade

4. Pharma Clinical Trial Services: Leading Developed Markets 2013-2023
4.1 Leading National Markets for Pharma Clinical Trial Services 2011
4.2 Pharma Clinical Trial Services: Leading National Market Forecasts 2013-2023
4.3 North America as a Destination for Clinical Trials
4.3.1 The US: The Largest National Market for Clinical Trial Services 2013-2023
4.3.1.1 Regulatory Developments to Improve Clinical Trials in the US
4.3.2 The US: Clinical Trial Service Revenue Forecast 2013-2023
4.4 The Outlook for Clinical Trial Services in Western Europe 2013-2023
4.4.1 Rewriting the Rules for Clinical Trials in the EU
4.4.2 Western Europe: Overall Market and Leading National Market Forecasts 2013-2023
4.4.3 Germany Is the Largest Market for Clinical Trial Services in Western Europe
4.4.4 France: Market Forecast 2013-2023
4.4.5 The UK
4.4.5.1 Overcoming Challenges in UK Clinical Trials
4.4.5.2 UK Clinical Trial Services Market Forecast 2013-2023
4.4.6 Italy
4.4.7 Spain: Market Forecast 2013-2023
4.5 Japan Is Being Challenged by Neighbouring Emerging Markets
4.5.1 Regulatory Policies Driving and Restraining Growth in Japan
4.5.2 Growth for Clinical Trial Services in Japan 2013-2023

5. Pharma Clinical Trial Services: Leading Emerging Markets 2013-2023
5.1 Leading Emerging Markets for Clinical Trial Services 2011
5.1.1 Benefits of Conducting Clinical Trials in Emerging National Markets
5.1.2 Challenges of Conducting Clinical Trials in Emerging Markets
5.2 Strong Growth Forecast for Emerging Clinical Trial Service Markets 2013-2023
5.3 Clinical Trials in Asia Pacific: An Emerging Market Perspective
5.3.1 India as a Hub for Clinical Trials
5.3.1.1 Increasingly Strict Regulatory Procedures in India
5.3.1.2 Indian Clinical Trial Services Market Forecast 2013-2023
5.3.2 China Will be the Largest Emerging Market for Clinical Trials Services in 2023
5.3.2.1 China Offers Many Advantages in Clinical Trials
5.3.2.2 New Guidelines for Phase I Trials
5.3.3 South Korea
5.3.3.1 Improving the Appeal of South Korea
5.3.3.2 Promoting Local Drug Development in So

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Regulatory Affairs Outsourcing Market (Services: Regulatory Affairs, Clinical Trial Applications and Product Registrations, Regulatory Writing and Publishing, Regulatory Consulting and Legal Representation and Others) - Global Industry Analysis, Size, Sha

Regulatory Affairs Outsourcing Market (Services: Regulatory Affairs, Clinical Trial Applications and Product Registrations, Regulatory Writing and Publishing, Regulatory Consulting and Legal Representation and Others) - Global Industry Analysis, Size, Sha

  • $ 4 795
  • Industry report
  • October 2014
  • by Transparency Market Research

This report on the regulatory affairs outsourcing market studies the current as well as future prospects of the market globally. Regulatory affairs outsourcing is rapidly gaining popularity in the global ...

Proteomics Markets for Research and IVD Applications

Proteomics Markets for Research and IVD Applications

  • $ 4 200
  • Industry report
  • September 2014
  • by Kalorama Information

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • October 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1784 biological ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.